[Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D000787:Angina Pectoris / Q000150:complications; D001381:Azepines / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004812:Epidemiologic Methods; D005069:Evaluation Studies as Topic; D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009574:Nitro Compounds / Q000627:therapeutic use; D012044:Regression Analysis; D012737:Sex Factors; D013223:Statistics as Topic; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001381:Azepines; D001565:Benzoates; D002301:Cardiac Glycosides; D009574:Nitro Compounds; D014665:Vasodilator Agents
Statistische Auswertung einer Gemeinschaftsstudie zur Untersuchung der Wirksamkeit des Koronartrainers Dilazep bei ischämischen Herzerkrankungen. 4. Mitteilung: Ergebnisse der zusammenfassenden Auswertung mit Faktorenanalyse und multipler Regressionsanalyse.